BCR-ABL tyrosine kinase inhibitors

AP4 Pill - white round

Generic Name: ponatinib

Pill with imprint AP4 is White, Round and has been identified as Iclusig 45 mg. It is supplied by ARIAD Pharmaceuticals, Inc.

Iclusig is used in the treatment of Acute Lymphoblastic Leukemia; Chronic Myelogenous Leukemia and belongs to the drug classes BCR-ABL tyrosine kinase inhibitors, multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Iclusig 45 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Iclusig (Ponatinib [ poe-na-ti-nib ])-AP4-45 mg-White-Round
Iclusig (Ponatinib [ poe-na-ti-nib ])-AP4-45 mg-White-Round

Iclusig
Generic Name: ponatinib [ poe-na-ti-nib ]
Imprint: AP4
Strength: 45 mg
Color: White
Size: N/A
Shape: Round
Availability: Prescription only
Drug Class: BCR-ABL tyrosine kinase inhibitors Multikinase inhibitors VEGF/VEGFR inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 76189-0534 (Discontinued)
Inactive Ingredients: Lactose monohydrate, Microcrystalline cellulose, Silicon dioxide, Magnesium stearate,
Latest News
Related Drugs